Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study
2017 ◽
Vol 107
(1)
◽
pp. 253-260.e1
◽
Keyword(s):
2017 ◽
Vol 15
(10)
◽
pp. 515-520
◽
2005 ◽
Vol 84
(4)
◽
pp. 985-995
◽
Keyword(s):
2015 ◽
Vol 29
(1)
◽
pp. 105-111
◽
Keyword(s):
2014 ◽
Vol 175
◽
pp. 191-193
◽
Keyword(s):
2010 ◽
Vol 70
(3)
◽
pp. 166-172
◽
Keyword(s):
2021 ◽
Vol 25
(4)
◽
pp. 354
Keyword(s):